imaging

Sneak peek: The Spline Feature

Third Sneak Peek: The Spline Feature
Another exciting reveal from the upcoming mTRIAL release!

Following the Lifewire tool, we’re thrilled to introduce Spline — a precision-driven feature that allows users to draw lesion outlines point by point. This manual approach gives full control over the shape and detail of the region of interest, making it ideal for complex or irregular lesions that require expert-level accuracy.

Whether you’re refining segmentation or preparing data for analysis, Spline empowers you to work with confidence and clarity.

Stay tuned — more innovations are on the way to transform your imaging workflow!

Sneak Peek: the Livewire Feature

We’re back with another exciting feature from our upcoming mTRIAL release.

Second Sneak Peek: The Livewire Feature
This powerful tool enables users to draw lesion outlines with threshold-based segmentation support, making it easier than ever to define and analyze regions of interest in medical imaging.

This is just one of many innovations coming your way — stay tuned for more features that will elevate your imaging experience!

Coming Soon: A new mTRIAL Release

The next version of mTRIAL is just around the corner — and it’s bringing a powerful upgrade to our DICOM Viewer!

First Sneak Peek: The Angulation Feature
With this new tool, you can:

Angulate in three dimensions for precise anatomical alignment
Measure in the selected imaging plane to enhance diagnostic accuracy

Stay tuned — more innovative features are on the way!

Imaging with Integrity

Imaging with Integrity: Creating Digital Trust from Day One

In clinical trials, patient centricity doesn’t stop at electronic consent—it begins there.

At mediri, we believe that true engagement continues through every step of the imaging journey. From site setup to central read, our integrated approach ensures that patients remain supported, data remains secure, and compliance becomes a natural outcome of thoughtful design.

With our mTRIAL platform, we enable:

Real-time feedback and transparent communication
AI-supported quality assurance for imaging data
Seamless, secure data exchange across multicentre trials
Custom workflows that align with study protocols and patient needs

By transforming imaging compliance into a patient-first experience, we help sponsors and sites build trust, improve data quality, and accelerate outcomes.

From consent to connection. From data to trust.

Let’s rethink the imaging journey—together.

How does your team ensure patient engagement beyond the consent form?

What is ASL?

Arterial Spin Labeling (ASL) represents a modern MRI technique for measuring perfusion, which modifies the magnetization of blood water protons to serve as natural tracers.
This method is entirely non-invasive, eliminating the need for ionizing radiation or external contrast agents.
The non-invasive nature of ASL provides numerous benefits for clinical research: it allows for repeated cerebral blood flow (CBF) measurements as often as needed and is suitable for use in vulnerable groups, such as patients with renal failure or pediatric patients.

Why It Matters: ASL offers a safe and effective way to measure cerebral perfusion, making it ideal for various clinical applications.

Have you heard about ASL before? Share your thoughts and experiences with us!

Seamless Integration for CROs

Your Challenge: Transferring measurement results manually between EDC systems of different vendors—costly, error-prone, and time-consuming.
Our Solution: Automatic API transfers that send measurement results directly into your existing systems.
Your Gain: Save time, reduce errors, and streamline your workflows like never before.
For CROs, we make efficiency effortless, so you can focus on what matters: delivering value to your clients.

New Project: SIMAB

Just imagine…you are planning a multi-center imaging study and you can choose whichever site you want irrespective of the MR scanner they have. In SIMAB, Fraunhofer MEVIS and mediri GmbH are developing a vendor-agnostic MR sequence development framework to increase the comparability of imaging biomarkers regardless of the employed scanner equipment.
Structural imaging biomarkers as brain atrophy or lesions will be assessed as well as functional indicators of neurological diseases, e.g. brain perfusion or permeability.
SIMAB is funded by the German Ministry for Research and Education.

20 years mediri GmbH

Today, we are filled with joy and gratitude as we celebrate our 20th anniversary.
Two decades of innovation, challenges, and successes are behind us. We are proud of what we have achieved together and extend our heartfelt thanks to our dedicated employees, loyal customers, and reliable partners for their support and trust.
Looking to the future, we are ready to explore new paths and continue developing innovative solutions that drive us forward. Together, we will shape the next years of success.

International Clinical Trials Day

Today is International Clinical Trials Day. Let’s celebrate this event and raise awareness about clinical trials while expressing our gratitude to all clinical research professionals worldwide.